Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Factors potentially associated with chemotherapy-induced anemia in patients with solid cancers.

Cheng K, Zhao F, Gao F, Dong H, Men HT, Chen Y, Li LH, Ge J, Tang J, Ding J, Chen X, Du Y, Luo WX, Liu JY.

Asian Pac J Cancer Prev. 2012;13(10):5057-61.

2.

Anemia in oncology practice: relation to diseases and their therapies.

Tas F, Eralp Y, Basaran M, Sakar B, Alici S, Argon A, Bulutlar G, Camlica H, Aydiner A, Topuz E.

Am J Clin Oncol. 2002 Aug;25(4):371-9.

PMID:
12151968
3.

Prevalence and characteristics of anemia in patients with solid cancers at diagnosis in southwest China.

Gao F, Cheng K, Zhao F, Chen Y, Li LH, Dong H, Men HT, Ge J, Tang J, Ding J, Chen X, Su JM, Liu JY.

Asian Pac J Cancer Prev. 2011;12(11):2825-8.

4.

Cancer anemia survey in Division of Medical Oncology at Siriraj Hospital (CAS).

Ithimakin S, Srimuninnimit V.

J Med Assoc Thai. 2009 Mar;92 Suppl 2:S110-8.

PMID:
19562994
5.

Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatient oncology practice database, 2000-2007.

Wu Y, Aravind S, Ranganathan G, Martin A, Nalysnyk L.

Clin Ther. 2009;31 Pt 2:2416-32. doi: 10.1016/j.clinthera.2009.11.020.

PMID:
20110050
6.

Anemia profiles in patients with lung cancer: what have we learned from the European Cancer Anaemia Survey (ECAS)?

Kosmidis P, Krzakowski M; ECAS Investigators.

Lung Cancer. 2005 Dec;50(3):401-12. Epub 2005 Sep 26.

PMID:
16191450
7.
8.

[The occurrence of anemia in small cell lung cancer patients during first-line chemotherapy].

Swiatoniowski G, Bruzewicz S, Bronowicz Z, Kłaniewski T.

Pol Merkur Lekarski. 2009 Feb;26(152):98-100. Polish.

PMID:
19388511
9.

Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer.

Hensley ML, Lebeau D, Leon LF, Venkatraman E, Waltzman R, Sabbatini P, Almadrones L, Chi D, Spriggs D.

Gynecol Oncol. 2001 Jun;81(3):485-9.

PMID:
11371143
10.

The anemia impact measure (AIM): development and content validation of a patient-reported outcome measure of anemia symptoms and symptom impacts in cancer patients receiving chemotherapy.

Kleinman L, Benjamin K, Viswanathan H, Mattera MS, Bosserman L, Blayney DW, Revicki DA.

Qual Life Res. 2012 Sep;21(7):1255-66. doi: 10.1007/s11136-011-0034-1. Epub 2011 Oct 11.

PMID:
21987032
11.

[Observation and clinical significance of adjuvant chemotherapy-induced amenorrhea in premenopausal breast cancer patients].

Li HP, Ma LW, Zhang SL, Jia TZ, Deng HJ, Zhang ZH, Liang L, Wang MP, Xiao Y, Cao BS, Chen S, Wang YF.

Zhonghua Zhong Liu Za Zhi. 2006 Nov;28(11):848-51. Chinese.

PMID:
17416008
13.

Hematologic outcomes and blood utilization in cancer patients with chemotherapy-induced anemia (CIA) pre- and post-national coverage determination (NCD): results from a multicenter chart review.

Henry DH, Langer CJ, McKenzie RS, Piech CT, Senbetta M, Schulman KL, Stepanski EJ.

Support Care Cancer. 2012 Sep;20(9):2089-96. doi: 10.1007/s00520-011-1318-2. Epub 2011 Dec 11.

PMID:
22160485
14.

Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study.

Oberhoff C, Neri B, Amadori D, Petry KU, Gamucci T, Rebmann U, Nowrousian MR, Voigtmann R, Monfardini S, Armand JP, Herrmann R, Netter-Pinon J, Tubiana-Mathieu N, Zwierzina H.

Ann Oncol. 1998 Mar;9(3):255-60.

15.

Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia.

Hernandez E, Ganly P, Charu V, Dibenedetto J, Tomita D, Lillie T, Taylor K; ARANESP 20030232 Study Group.

Curr Med Res Opin. 2009 Sep;25(9):2109-20. doi: 10.1185/03007990903084164.

PMID:
19601709
16.

Treatment of chemotherapy-induced anemia in ovarian cancer patients: does the use of erythropoiesis-stimulating agents worsen survival?

Rocconi RP, Sullivan P, Long B, Blaize M, Brown J, Arbuckle J, Bevis K, Estes JM, Reed E, Finan MA.

Int J Gynecol Cancer. 2012 Jun;22(5):786-91. doi: 10.1097/IGC.0b013e31825104f4.

PMID:
22552832
17.

Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens.

Pérez-Fidalgo JA, Roselló S, García-Garré E, Jordá E, Martín-Martorell P, Bermejo B, Chirivella I, Guzman C, Lluch A.

Breast Cancer Res Treat. 2010 Feb;120(1):245-51. doi: 10.1007/s10549-009-0426-x. Epub 2009 Jul 3.

PMID:
19575291
19.

Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: an observational retrospective survey.

Repetto L; CIPOMO investigators.

Crit Rev Oncol Hematol. 2009 Nov;72(2):170-9. doi: 10.1016/j.critrevonc.2009.03.004. Epub 2009 Apr 29.

PMID:
19406660
20.

Predicting cancer-associated anaemia in patients receiving non-platinum chemotherapy: results of a retrospective survey.

Coiffier B, Guastalla JP, Pujade-Lauraine E, Bastit P; Anemia Study Group.

Eur J Cancer. 2001 Sep;37(13):1617-23.

PMID:
11527686
Items per page

Supplemental Content

Write to the Help Desk